Matthew Weinberg Writes for Tobacco Reporter

June 17, 2014

CEO Matthew Weinberg writes for Tobacco Reporter Magazine encouraging stakeholders to take advantage of the opportunity to respond to FDA e-cigarette regulations.




June 17, 2014

Drug Companies Face Stricter Clinical Trial Regulation Worldwide

For more information on The Weinberg Group’s independent clinical auditing services, please contact Jeff Antos at jeff.antos@weinberggroup.com or 202.280.0815.

Read More

June 17, 2014

Matthew Weinberg Writes for International Clinical Trials (ICT) Magazine

In this article CEO Matthew Weinberg discusses the downsides to self-auditing good clinical practice and the need smaller, more proactive audits, on the other hand, can provide a more intelligent...

Read More

June 17, 2014

CEO Matthew Weinberg Presents at FDA Clinical Trials Hearing

April 23 - The Weinberg Group CEO, Matthew Weinberg, presented today at FDA’s hearing titled “Modernizing the Regulation of Clinical Trials and Approaches to Good Clinical Practice.”  Mr. Weinberg...

Read More